Reasons why access cannot be provided (enquiries for GSK studies)
| Reason |
Number of studies |
| No data available |
29 |
| GSK does not have the legal authority |
21 |
| Not accepted for publication |
22 |
| Foreign language |
9 |
| Medicine not approved or terminated * |
3 |
| Rare disease study with risk of re-identification |
2 |
| Patient informed consent form restriction
|
0 |
*Applicable up to April 2016
| 618 |
GSK |
| 633 |
GSK |
| 690 |
GSK |
| 938 |
BI/GSK/Roche |
| 941 |
Roche |
| 1047 |
GSK |
| 1087 |
GSK |
| 1107 |
GSK |
| 1589 |
Novartis |
| Proposal number
|
Study Sponsor(s)/funder(s)
|
Reason(s)
|
| 615 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 618 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 633 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 690 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 931 |
BI/GSK |
The Research Proposal did not meet the Sponsor
policies for informed consent |
| 938 |
BI/GSK/Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
| 941 |
Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1047 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1087 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1107 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1552 |
Novartis |
The proposed research required data that was not collected in the studies requested |
| 1235 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
| 1245 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
| 1589 |
Novartis |
The Research Proposal is not seeking access to anonymised patient level data |